130.35
price up icon1.99%   2.5045
 
loading
Precedente Chiudi:
$127.85
Aprire:
$129.44
Volume 24 ore:
279.95K
Relative Volume:
0.19
Capitalizzazione di mercato:
$19.10B
Reddito:
$9.82B
Utile/perdita netta:
$1.48B
Rapporto P/E:
12.87
EPS:
10.13
Flusso di cassa netto:
$2.30B
1 W Prestazione:
+1.50%
1M Prestazione:
+4.51%
6M Prestazione:
-9.24%
1 anno Prestazione:
-41.87%
Intervallo 1D:
Value
$128.36
$130.70
Intervallo di 1 settimana:
Value
$121.05
$130.70
Portata 52W:
Value
$110.03
$236.48

Biogen Inc Stock (BIIB) Company Profile

Name
Nome
Biogen Inc
Name
Telefono
(781) 464-2000
Name
Indirizzo
225 BINNEY STREET, CAMBRIDGE, MA
Name
Dipendente
7,605
Name
Cinguettio
@biogen
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
BIIB's Discussions on Twitter

Confronta BIIB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
BIIB
Biogen Inc
130.38 18.68B 9.82B 1.48B 2.30B 10.13
Drug Manufacturers - General icon
LLY
Lilly Eli Co
787.47 692.83B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
167.15 373.35B 90.63B 22.66B 18.57B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
188.20 329.24B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
116.91 231.66B 55.19B 13.65B 16.81B 6.86
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
69.55 298.68B 43.59B 15.04B 10.74B 3.3766

Biogen Inc Stock (BIIB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-21 Ripresa Truist Hold
2025-04-28 Downgrade HSBC Securities Buy → Hold
2025-04-04 Downgrade Argus Buy → Hold
2025-02-11 Iniziato Bernstein Mkt Perform
2025-01-02 Downgrade Piper Sandler Overweight → Neutral
2024-12-20 Downgrade BMO Capital Markets Outperform → Market Perform
2024-12-16 Downgrade Stifel Buy → Hold
2024-12-10 Ripresa BofA Securities Neutral
2024-12-09 Downgrade Jefferies Buy → Hold
2024-11-18 Downgrade Needham Buy → Hold
2024-11-15 Iniziato Wolfe Research Peer Perform
2024-11-14 Iniziato Citigroup Neutral
2024-10-31 Downgrade Morgan Stanley Overweight → Equal-Weight
2024-10-10 Ripresa Raymond James Mkt Perform
2024-02-14 Reiterato Needham Buy
2024-02-14 Downgrade Wells Fargo Overweight → Equal Weight
2024-01-24 Downgrade UBS Buy → Neutral
2023-12-20 Ripresa Cantor Fitzgerald Overweight
2023-12-07 Aggiornamento Raymond James Mkt Perform → Outperform
2023-09-06 Iniziato HSBC Securities Buy
2023-07-27 Iniziato Scotiabank Sector Outperform
2023-07-24 Reiterato UBS Buy
2023-05-01 Aggiornamento Guggenheim Neutral → Buy
2023-04-17 Aggiornamento Piper Sandler Neutral → Overweight
2022-10-26 Aggiornamento Goldman Neutral → Buy
2022-10-13 Aggiornamento Stifel Hold → Buy
2022-10-07 Aggiornamento Argus Hold → Buy
2022-09-28 Aggiornamento BMO Capital Markets Market Perform → Outperform
2022-09-28 Aggiornamento Mizuho Neutral → Buy
2022-09-28 Aggiornamento Robert W. Baird Neutral → Outperform
2022-04-18 Aggiornamento Wells Fargo Equal Weight → Overweight
2022-03-08 Downgrade Stifel Buy → Hold
2022-03-03 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2022-02-04 Downgrade BMO Capital Markets Outperform → Market Perform
2022-02-04 Reiterato Barclays Equal Weight
2022-02-04 Reiterato BofA Securities Neutral
2022-02-04 Reiterato Cowen Outperform
2022-02-04 Reiterato Morgan Stanley Overweight
2022-02-04 Reiterato Needham Buy
2022-02-04 Reiterato Oppenheimer Outperform
2022-02-04 Reiterato RBC Capital Mkts Sector Perform
2022-02-04 Reiterato Robert W. Baird Neutral
2022-02-04 Reiterato Wedbush Neutral
2022-02-04 Reiterato Wells Fargo Equal Weight
2022-02-04 Reiterato Wolfe Research Peer Perform
2022-01-13 Downgrade Guggenheim Buy → Neutral
2022-01-12 Downgrade Piper Sandler Overweight → Neutral
2021-12-10 Ripresa Raymond James Mkt Perform
2021-12-09 Ripresa Wells Fargo Equal Weight
2021-12-06 Iniziato Goldman Neutral
2021-11-19 Iniziato BMO Capital Markets Outperform
2021-09-23 Iniziato Needham Buy
2021-06-18 Aggiornamento Piper Sandler Neutral → Overweight
2021-06-14 Reiterato Truist Buy
2021-06-11 Aggiornamento Bernstein Mkt Perform → Outperform
2021-06-10 Aggiornamento UBS Neutral → Buy
2021-06-08 Aggiornamento Atlantic Equities Underweight → Neutral
2021-06-08 Reiterato Barclays Equal Weight
2021-06-08 Aggiornamento Citigroup Sell → Neutral
2021-06-08 Reiterato H.C. Wainwright Buy
2021-06-08 Reiterato Jefferies Buy
2021-06-08 Reiterato Morgan Stanley Overweight
2021-06-08 Reiterato RBC Capital Mkts Sector Perform
2021-06-08 Aggiornamento Robert W. Baird Underperform → Neutral
2021-06-08 Reiterato Stifel Buy
2021-06-08 Aggiornamento William Blair Mkt Perform → Outperform
2021-06-07 Aggiornamento BofA Securities Underperform → Neutral
2021-06-07 Aggiornamento Cowen Market Perform → Outperform
2021-06-07 Aggiornamento Raymond James Underperform → Mkt Perform
2021-02-05 Downgrade DZ Bank Buy → Hold
2021-01-29 Aggiornamento Stifel Hold → Buy
2020-11-10 Aggiornamento DZ Bank Hold → Buy
2020-11-09 Downgrade Atlantic Equities Neutral → Underweight
2020-11-09 Downgrade BofA Securities Neutral → Underperform
2020-11-09 Downgrade Cowen Outperform → Market Perform
2020-11-09 Reiterato H.C. Wainwright Buy
2020-11-04 Aggiornamento BofA Securities Underperform → Neutral
2020-11-04 Aggiornamento Jefferies Hold → Buy
2020-11-04 Aggiornamento Wells Fargo Equal Weight → Overweight
2020-10-28 Iniziato UBS Neutral
2020-07-27 Aggiornamento Morgan Stanley Underweight → Overweight
2020-06-22 Downgrade Barclays Overweight → Equal Weight
2020-06-22 Reiterato RBC Capital Mkts Sector Perform
2020-06-09 Downgrade Bernstein Outperform → Mkt Perform
2020-04-23 Downgrade Citigroup Neutral → Sell
2020-04-23 Downgrade Raymond James Mkt Perform → Underperform
2020-03-31 Iniziato Wolfe Research Peer Perform
2020-02-27 Iniziato Barclays Overweight
2020-01-27 Aggiornamento Canaccord Genuity Hold → Buy
2019-12-13 Aggiornamento Credit Suisse Underperform → Neutral
2019-12-02 Downgrade Robert W. Baird Neutral → Underperform
Mostra tutto

Biogen Inc Borsa (BIIB) Ultime notizie

pulisher
06:38 AM

KLP Kapitalforvaltning AS Has $21.36 Million Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

06:38 AM
pulisher
05:12 AM

Biogen to invest $2 billion in RTP, open new factory in 2025 - WRAL.com

05:12 AM
pulisher
04:33 AM

Envestnet Asset Management Inc. Increases Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

04:33 AM
pulisher
02:35 AM

Will Major North Carolina Expansion Change Biogen's (BIIB) Narrative? - simplywall.st

02:35 AM
pulisher
Jul 22, 2025

Biogen Inc. Stock Analysis and ForecastExceptional ROI - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Beacon Investment Advisory Services Inc. Sells 3,529 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division - Benzinga

Jul 22, 2025
pulisher
Jul 22, 2025

Biogen, one of the largest employers in RTP, plans $2B investment in the Triangle - Axios

Jul 22, 2025
pulisher
Jul 22, 2025

How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings? - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Allianz Asset Management GmbH Increases Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Los Angeles Capital Management LLC Takes $5.93 Million Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Spinal Muscular Atrophy Treatment Market Growth Accelerated - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Biogen Inc. a good long term investmentExplosive wealth accumulation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Biogen Inc. stock pricePowerful growth strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Biogen: Hold Rating Amid Stagnant Growth and Uncertain Prospects - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Biogen to invest additional $2B in North Carolina’s Research Triangle Park - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

Biogen to invest further $2bn in North Carolina’s Research Triangle Park - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Iovance Biotherapeutics shares rise 2.41% premarket after Biogen's $2 billion investment in North Carolina manufacturing. - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Biogen Inc. stockFree Predictions - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Biogen investing $2B to expand operations in RTP - ABC11

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen's Alzheimer's Innovation Pipeline: Lecanemab and BIIB080 as Catalysts for Long-Term Growth - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen & Partner Eisai Get EU Nod for Alzheimer's Drug Leqembi - yahoo.co

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025 - Biogen

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen Inc. - Via Ritzau

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen to invest $2 billion in RTP facility - CBS 17

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen Inc. Invests $2B In North Carolina Expansion - Business Facilities

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen Inc. Announces $2 Billion Expansion in North Carolina's Research Triangle Park Amid U.S. Manufacturing Push - Hoodline

Jul 21, 2025
pulisher
Jul 21, 2025

Friedreich's Ataxia Market Is Expanding Due To Advancing - openPR.com

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen (BIIB) Stock Trades Down, Here Is Why - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen Bets Big On $2 Billion Expansion To Boost US Drug ManufacturingBiogen (NASDAQ:BIIB) - Benzinga

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen invests $2B in U.S. manufacturing — but not in Massachusetts - The Business Journals

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen to invest $2 billion in Research Triangle Park facilities - CBS 17

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen’s Pediatric RRMS Study Completion: Market Implications and Insights - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen (NASDAQ:BIIB) Coverage Initiated by Analysts at Truist Financial - MarketBeat

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen Invests $20 Billion in North Carolina to Counter 200% Tariff Threat - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen to invest further $2 billion in North Carolina facilities - The Pharma Letter

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm - Reuters

Jul 21, 2025
pulisher
Jul 21, 2025

Drugmaker Biogen to invest $2 billion more in North Carolina - 104.1 WIKY

Jul 21, 2025
pulisher
Jul 21, 2025

Truist downgrades Biogen, citing growth challenges, limited pipeline upside - TradingView

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen Announces Additional Investment In North Carolina's RTP - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen (BIIB) Increases Investment in North Carolina Manufacturi - GuruFocus

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen to invest $2 billion more in North Carolina By Reuters - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen Announces $2 Billion Manufacturing Investment in North Carolina's Research Triangle Park in Conjunction with its 30th Anniversary | BIIB Stock News - GuruFocus

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen to invest $2 billion in North Carolina manufacturing expansion By Investing.com - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen Announces $2 Billion Investment to Expand Manufacturing in North Carolina's Research Triangle Park - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen to invest $2 billion more in North Carolina - Reuters

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary - The Manila Times

Jul 21, 2025
pulisher
Jul 21, 2025

Biogen Commits $2B for Manufacturing Expansion in Research Triangle Park | BIIB Stock News - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

Twin Capital Management Inc. Has $1.58 Million Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Jul 21, 2025
pulisher
Jul 21, 2025

Central Nervous System (CNS) Biomarkers Market is expected - openPR.com

Jul 21, 2025

Biogen Inc Azioni (BIIB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general SNY
$49.69
price up icon 1.89%
$112.11
price up icon 1.79%
drug_manufacturers_general PFE
$25.34
price up icon 0.81%
$307.56
price up icon 0.42%
drug_manufacturers_general MRK
$82.87
price up icon 1.57%
drug_manufacturers_general NVO
$69.56
price up icon 4.04%
Capitalizzazione:     |  Volume (24 ore):